Awake extracorporeal membrane oxygenation support for a critically ill COVID-19 patient: A case report.
Awake extracorporeal membrane oxygenation
COVID-19
Case report
Prone position ventilation
Rehabilitation
Journal
World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806
Informations de publication
Date de publication:
26 Jul 2021
26 Jul 2021
Historique:
received:
30
11
2020
revised:
30
03
2021
accepted:
15
05
2021
entrez:
9
8
2021
pubmed:
10
8
2021
medline:
10
8
2021
Statut:
ppublish
Résumé
A critically ill coronavirus disease 2019 (COVID-19) patient complicated by acute respiratory distress syndrome is reported. The patient survived following treatment with awake veno-venous extracorporeal membrane oxygenation (ECMO). A 53-year-old male patient attended our hospital following a cough for 11 d and fever for 9 d. According to his computed tomography (CT) scan and real-time reverse transcription-polymerase chain reaction assay of a throat swab, nucleic acid was positive, confirming that he had COVID-19. He was subsequently transferred to the intensive care unit due to respiratory failure. The patient received antiviral drugs, a small dose of glucocorticoid, and respiratory support, including mechanical ventilation, but the treatment effect was poor. On the 28 COVID-19 can damage lung tissues and cause evident inflammatory exudation, thus affecting oxygenation function. Awake ECMO, PPV, and comprehensive rehabilitation are effective in patients with critical COVID-19 and respiratory failure.
Sections du résumé
BACKGROUND
BACKGROUND
A critically ill coronavirus disease 2019 (COVID-19) patient complicated by acute respiratory distress syndrome is reported. The patient survived following treatment with awake veno-venous extracorporeal membrane oxygenation (ECMO).
CASE SUMMARY
METHODS
A 53-year-old male patient attended our hospital following a cough for 11 d and fever for 9 d. According to his computed tomography (CT) scan and real-time reverse transcription-polymerase chain reaction assay of a throat swab, nucleic acid was positive, confirming that he had COVID-19. He was subsequently transferred to the intensive care unit due to respiratory failure. The patient received antiviral drugs, a small dose of glucocorticoid, and respiratory support, including mechanical ventilation, but the treatment effect was poor. On the 28
CONCLUSION
CONCLUSIONS
COVID-19 can damage lung tissues and cause evident inflammatory exudation, thus affecting oxygenation function. Awake ECMO, PPV, and comprehensive rehabilitation are effective in patients with critical COVID-19 and respiratory failure.
Identifiants
pubmed: 34368315
doi: 10.12998/wjcc.v9.i21.5963
pmc: PMC8316967
doi:
Types de publication
Case Reports
Langues
eng
Pagination
5963-5971Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare no competing interests.
Références
Open Forum Infect Dis. 2020 Mar 23;7(4):ofaa105
pubmed: 32284951
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Transfus Med Rev. 2015 Apr;29(2):90-101
pubmed: 25595476
Respir Physiol Neurobiol. 2009 Jun 30;167(2):181-8
pubmed: 19505674
Anaesthesist. 2016 Apr;65(4):250-7
pubmed: 27007777
CMAJ. 2008 Apr 22;178(9):1153-61
pubmed: 18427090
New Microbes New Infect. 2020 Nov;38:100770
pubmed: 33014380
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
J Med Virol. 2021 Mar;93(3):1204-1206
pubmed: 32880995
Cell Discov. 2020 Oct 29;6(1):76
pubmed: 33298872
Crit Care. 2013 Apr 29;17(2):225
pubmed: 23672857
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Eur J Pharmacol. 2021 Jan 5;890:173646
pubmed: 33190802
Crit Care. 2016 Jun 30;20(1):150
pubmed: 27357690
Ann Thorac Surg. 2021 Feb;111(2):623-628
pubmed: 32171730
N Engl J Med. 2018 May 24;378(21):1965-1975
pubmed: 29791822
J Thorac Dis. 2016 Jan;8(1):37-42
pubmed: 26904210
Intensive Care Med. 2010 Apr;36(4):585-99
pubmed: 20130832
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020 Apr 25;37(2):236-245
pubmed: 32329275
JAMA Netw Open. 2020 Apr 24;3(4):e208857
pubmed: 32330277
Cell. 2020 May 14;181(4):954-954.e1
pubmed: 32413300
Crit Care Med. 2015 Mar;43(3):654-64
pubmed: 25565460
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Lancet. 2009 Oct 17;374(9698):1351-63
pubmed: 19762075
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Intensive Care Med. 2000 Nov;26(11):1664-9
pubmed: 11193274
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758